Related Experiment Video
Updated: Jul 2, 2025

05:00
Using a Chemical Biopsy for Graft Quality Assessment
Published on: June 17, 2020
5.2K
Unexpected Medical Conditions Discovered During Live Donor Kidney Evaluation: Single Center Study.
Alexandra Lee1, George Bayliss2, Adena Osband3
1Medical Student, Alpert Medical School of Brown University.
Rhode Island Medical Journal (2013)
|February 27, 2024
Summary
Many potential living kidney donors are excluded due to newly diagnosed conditions like kidney issues, diabetes, and hypertension. Early detection and intervention are crucial for donor health and successful transplantation outcomes.
Area of Science:
- Nephrology
- Transplant Surgery
- Public Health
Background:
- Living donor kidney transplantation (LDKT) is the preferred treatment for end-stage kidney disease.
- Potential living kidney donors (PLKDs) undergo rigorous screening to ensure safety.
- An increasing number of PLKDs are being excluded due to conditions identified during screening.
Purpose of the Study:
- To investigate local trends in PLKD exclusion rates.
- To identify newly diagnosed conditions leading to exclusion.
- To analyze exclusion trends by age, race, and sex.
Main Methods:
- Retrospective electronic medical record review.
- Analysis of 429 PLKDs screened at Rhode Island Hospital Kidney Transplant Center (December 2012 - April 2023).
- Data collected included age, race, gender, relationship to recipient, and exclusion reasons.
Main Results:
- 115 out of 429 PLKDs (26.8%) were excluded for newly diagnosed conditions.
- Most common diagnoses: renal issues (49%), diabetes mellitus (33%), hypertension (13%).
- Many excluded donors had comorbid diagnoses.
Conclusions:
- Newly diagnosed, treatable conditions are a significant reason for PLKD exclusion.
- High prevalence suggests potential gaps in primary care and healthcare continuity.
- Emphasizes the importance of early intervention and follow-up care for excluded PLKDs.
Related Concept Videos
Bone Marrow Sampling and Transplants
330
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
330
Tissue Transplantation
366
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
366

